| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Molecular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [J. U. G., D. C.], and Department of Radiotherapy, Loyola University Chicago-Hines VAMC, Hines, Illinois 60141 [D. C.]
p202 is an IFN-inducible, primarily nuclear, phosphoprotein (52-kDa) whose constitutive overexpression in transfected cells inhibits colony formation. To investigate the molecular mechanism(s) by which expression of p202 protein impairs colony formation, we established stable cell lines that inducibly express p202. Using this cell model, we demonstrate that the induced expression of p202 in asynchronous cultures of these cells was accompanied by: (a) an increase in steady-state levels of p21WAF1/CIP1/SDI1 (p21) mRNA and protein; (b) a decrease in Cdk2 protein kinase activity; and (c) an increase in the functional form of retinoblastoma protein (pRb). Transient transfection of a p202-encoding plasmid in Saos-2 cells, which do not harbor a wild-type p53 protein, resulted in an increase in p21 protein, which indicated that p202 could regulate expression of p21 protein independent of p53 protein. Moreover, we demonstrate that expression of p202 in these cells increased cell doubling time without accumulation of cells in a particular phase of the cell cycle. Taken together, these results are consistent with the possibility that p202 protein contributes to the cell growth retardation activity of the IFNs, at least in part, by modulating p21 protein levels.
This article has been cited by other articles:
![]() |
R. Wessely Interference by interferons: Janus faces in vascular proliferative diseases Cardiovasc Res, June 1, 2005; 66(3): 433 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dermott, J. M. Gooya, B. Asefa, S. R. Weiler, M. Smith, and J. R. Keller Inhibition of Growth by p205: A Nuclear Protein and Putative Tumor Suppressor Expressed during Myeloid Cell Differentiation Stem Cells, September 1, 2004; 22(5): 832 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pramanik, T. N. Jorgensen, H. Xin, B. L. Kotzin, and D. Choubey Interleukin-6 Induces Expression of Ifi202, an Interferon-inducible Candidate Gene for Lupus Susceptibility J. Biol. Chem., April 16, 2004; 279(16): 16121 - 16127. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Kwak, P. P. Ongusaha, T. Ouchi, and S. W. Lee IFI16 as a Negative Regulator in the Regulation of p53 and p21Waf1 J. Biol. Chem., October 17, 2003; 278(42): 40899 - 40904. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goodbourn, L. Didcock, and R. E. Randall Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol., October 1, 2000; 81(10): 2341 - 2364. [Full Text] |
||||
![]() |
Y. Geng, S. DSouza, H. Xin, S. Walter, and D. Choubey p202 Levels Are Negatively Regulated by Serum Growth Factors Cell Growth Differ., September 1, 2000; 11(9): 475 - 483. [Abstract] [Full Text] |
||||
![]() |
H. Wang, C.-j. Liu, Y. Lu, G. Chatterjee, X.-Y. Ma, R. N. Eisenman, and P. Lengyel The Interferon- and Differentiation-inducible p202a Protein Inhibits the Transcriptional Activity of c-Myc by Blocking Its Association with Max J. Biol. Chem., August 25, 2000; 275(35): 27377 - 27385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D'Souza, H. Xin, S. Walter, and D. Choubey The Gene Encoding p202, an Interferon-inducible Negative Regulator of the p53 Tumor Suppressor, Is a Target of p53-mediated Transcriptional Repression J. Biol. Chem., January 5, 2001; 276(1): 298 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fajas, C. Paul, O. Zugasti, L. Le Cam, J. Polanowska, E. Fabbrizio, R. Medema, M.-L. Vignais, and C. Sardet pRB binds to and modulates the transrepressing activity of the E1A-regulated transcription factor p120E4F PNAS, July 5, 2000; 97(14): 7738 - 7743. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |